GAP-Net site Brigham and Women’s CART was featured with two of their Citizen Scientists in the Boston Business Journal about COVID-related delays and the dedication of AD volunteers. Joining a clinical trial may not be the first idea that pops into your head when wondering how to make new friends after moving to a new […]
GAP-Net site, UCI Mind at the University of California Irvine, was awarded an Alzheimer’s research grant by the National Institute of Health The National Institutes of Health has awarded $14.4 million to the UCI MIND institute at UC Irvine to continue its crucial work in the study of Alzheimer’s disease, for which there remains no […]
GAP President John Dwyer wrote a piece in The Hill urging Congress to ensure research centers involved in Alzheimer’s clinical trials will have access to COVID-19 relief funds. COVID-19 has had a devastating impact on clinical trials and the medical research infrastructure that scientists depend upon to develop new drugs for Alzheimer’s and all the diseases we fear most. Without action, […]
GAP President, John Dwyer, and GAP-Net site Great Lakes Clinical Trial spoke on the hit Alzheimer’s clinical trials have taken since COVID-19, and the losses that will come of it. After a frustrating 2019, Alzheimer’s researchers had reason to look forward to 2020 as a year of promise. Then the pandemic struck. “Last year, seven […]
Alice Bailey, a GAP Citizen Scientist Award nominee, wrote an Op-Ed piece in the Cambridge Chronicle about her experience as an Alzheimer’s patient and clinical trial volunteer. For many seniors, Alzheimer’s disease is surrounded by fear. Fear of the diagnosis can be so strong that some don’t want to learn about or talk about the […]
GAP President John Dwyer and GAP-Net Site Roper St. Francis Healthcare Research and Innovation Center in Charleston, South Carolina were featured on LIVE 5 WCSC News about the need for Alzheimer’s clinical trials to begin again. CHARLESTON, S.C. (WCSC) – Medical experts are worried that the COVID-19 pandemic has put delays on the search for […]
GAP President John Dwyer was quoted in AlzForum about the challenges and changes in Alzheimer’s clinical trials due to COVID-19. As Alzheimer’s research comes to, scientists are taking stock of the damage. In the academic world, the main cost was time (see Part 1 of this story). For most clinical studies, the damage was more tangible, with […]
GAP-Net Site, Brigham and Women’s Center for Alzheimer’s Research and Treatment, and GAP President, John Dwyer, were featured on Boston 25 News talking about how Alzheimer’s Clinical Trial volunteers and researchers are getting back on track after COVID-19 setbacks. The pandemic has put a pause on critical medical research. At Brigham and Women’s Hospital, some […]
GAP-Net site Great Lakes Clinical Trials in Chicago was featured in the Chicago Sun Times, where they discussed the difficulties of attracting Alzheimer’s disease trial participants during COVID-19. Jim Butler is receiving his monthly 45-minute infusion of drugs. What kind of drugs? He doesn’t know. Nor do the nurses administering them. Could be an experimental […]
In February, Stomping Ground Comedy Theater lead a workshop for caregivers about how to best interact with loved ones living with Alzheimer’s disease or dementia. They also attended our 2020 GAP-Net Site Optimization Conference at the end of February. Above Photo: Lindsey Goldsapp of Stomping Ground Comedy Theater leads a workshop for caregivers at the […]
This editorial was run in the Kelowna Daily Courier on May 20, 2020, on Clinical Trials Day during Clinical Trial Awareness Week. Dr. Kim Christie is the President of GAP-Net Site Okanagan Clinical Trials in Kelowna, British Columbia in Canada. Today is Clinical Trials Day, an observance commemorating the first controlled clinical trial conducted by […]
GAP-Net Site, the University of Kansas Alzheimer’s Disease Center’s (KU ADC) Outreach, Recruitment and Education Core earned the 2020 University of Kansas Medical Center Diversity, Equity and Inclusion Award. The University of Kansas Alzheimer’s Disease Center’s Outreach, Recruitment and Education Core earned the 2020 University of Kansas Medical Center Diversity, Equity and Inclusion Award. Presented […]
Dorene M. Rentz, PsyD, from GAP-Net site Brigham and Women’s Center for Alzheimer’s Research and Treatment, and Professor of Neurology at Harvard Medical School co-authored Costs of Early Stage Alzheimer’s Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1. You can find the study posted in The Journal of Alzheimer’s Disease […]
Global Alzheimer’s Platform Foundation president, John Dwyer, was quoted on how GAP is supporting GAP-Net sites during the COVID-19 pandemic, emphasizing the importance of safety and remote clinical trial testing. The coronavirus pandemic is upending not only life as we knew it, but Alzheimer’s clinical studies as well. In the United States, Europe, and Australia, […]
A participant might commit months or years to a drug trial, only to see it vanish overnight. On March 21, 2019, the staff at the Penn Memory Center in Philadelphia was scrambling to learn more about an early-morning announcement: Two pharmaceutical companies, Biogen and Eisai, would discontinue their clinical trial of a drug intended to […]
A site in the Global Alzheimer’s Platform Foundation’s network, ClinCloud Clinical Research, was featured on FOX35 Orlando on March 4, 2020 at 6pm. Click here to watch the segment. MAITLAND, Fla. – Researchers have been spending years trying to cure Alzheimer’s Disease. We’ve seen several medical breakthroughs in Central Florida, but they are still running into problems. They […]
This past week, the Global Alzheimer’s Platform Foundation, which works with a national network of clinical research centers, held its annual Site Optimization Conference in Orlando. The conference brings together the leaders of more than 80 clinical trial sites throughout the U.S. and Canada who work day in and day out to identify a cure […]
A Spanish translation of the article below can be found on Orlando Sentenial posted on February 27, 2020 by Ginayra Alvarado Villegas. According to statistics from the Alzheimer’s Association in the United States, every 65 seconds a person develops Alzheimer’s disease, a disease that has doctors and researchers conducting studies to develop a drug or […]
CHICAGO, Feb. 27, 2020 /PRNewswire/ — The number of commercially insured Americans age 30 to 64 diagnosed with early-onset dementia or Alzheimer’s disease increased by 200% from 2013 to 2017. The average age of a person living with either form of dementia is 49. The findings came from a new Blue Cross Blue Shield Association (BCBSA) report, “Early-Onset […]
The Global Alzheimer’s Platform Foundation recognizes the impact that GAP-Net site Georgetown University Medical Center’s Memory Disorders Program has had on Alzheimer’s disease research. We congratulate them on their 20 years of dedication and service to the field. WASHINGTON (WJLA) — It’s estimated that one in 10 people 65 and over has Alzheimer’s disease. That’s nearly […]
The Global Alzheimer’s Platform Foundation is proud and honored to work with GAP Net site Butler Hospital Memory and Aging Program’s Dr. Stephen Salloway, who was named Rhode Island’s Man of the Year for 2019. It is the cruelest of diseases. It is the sixth leading cause of death in America. In the United States, […]
Al Sharpton delivered the keynote address for the Black Health Care Coalition, speaking out against the health care of black people and specifically Alzheimer’s. Turning his attention to the upcoming 2020 election, Sharpton says “All of the candidates running for President of the United States have health plans and should be focusing to eliminate the […]
CLEVELAND, Ohio — Alzheimer’s disease afflicts nearly 6 million people in the United States, and sadly affects the many more millions of people who love them. Yet the chairman and co-founder of UsAgainstAlzheimer’s believes that most people — especially those who could help make a difference — don’t grasp the overall scope and impact of […]
CLEVELAND, Ohio — The long quest to find a cure for Alzheimer’s disease could become discouraging. But ordinary people won’t allow that. They are a source of encouragement for doctors and researchers dedicated to stifling the disease, and for the people stricken by it. “Participating in a clinical trial gives me and others the opportunity […]